Medigene AG Expands Its End-To-End Platform By Submitting Three Development Optimization Technology Patents To The European Patent Office
Source: menafn.com
End To Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from End To Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In End To Platform Today - Breaking & Trending Today
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
Planegg/Martinsried, May 21, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of differentiated T cell immunotherapies for solid tumors and BioNTech SE...
Source: marketscreener.com
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond ...
Planegg/Martinsried, May 21, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of differentiated T cell immunotherapies for
Source: smdailyjournal.com
Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
Planegg/Martinsried, May 2, 2024. Medigene AG , an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, presented superior T cell...
Source: marketscreener.com
Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T ...
Planegg/Martinsried, May 2, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid
Source: smdailyjournal.com